Comment on

• Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

  Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. Mueller C, et al. N Engl J Med. 2004 Feb 12;350(7):647-54. doi: 10.1056/NEJMoa031681. N Engl J Med. 2004. PMID: 14960741 Clinical Trial.
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Wang TJ, et al. N Engl J Med. 2004 Feb 12;350(7):655-63. doi: 10.1056/NEJMoa031994. N Engl J Med. 2004. PMID: 14960742